Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

NCT00659074 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ondansetron
DRUG: Zofran

Sponsor

Par Pharmaceutical, Inc.

Collaborators

[object Object]